According to the report titled ‘Europe Aesthetic Medicine Market Size By Gender, By Type, By Product, By End-use, Research Report, Country Outlook, Price Trends, Growth Prospects, COVID-19 Impact Statistics, Competitive Industry Share & Forecasts, 2021 – 2027’, available with Market Study Report, Europe aesthetic medicine market value is anticipated to multiply substantially during 2021-2027.
 

Rising awareness about aesthetic treatments among the masses owing to internet accessibility and high social media exposure, surge in geriatric population, and increase in disposable income in emerging countries are majorly driving the growth of Europe aesthetic medicine market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3963040/
 

In addition, soaring accidental cases leading to rise in the number of cosmetic operations, along with popularization of non-energy based goods like injectables and implants are further stimulating the industry outlook.
 

Minimized treatment risks, affordability of cosmetic procedures, coupled with amplifying medical spa chains, presence of highly qualified & skilled cosmetic surgeons, and growing prevalence of skin diseases are also generating revenues for the industry.
 

By type, Europe aesthetic medicine market sphere is split into surgical, and non-surgical, whereas, fragmentation on the basis of product terrain includes energy based (laser-based aesthetic device, radiofrequency-based aesthetic device, ultrasound aesthetic device, light-based aesthetic device, others), non-energy based (botulinum toxin, implants, dermal fillers, breast implants, facial implants, others), and others.
 

The non-surgical segment amassed notable gains in 2020 and is expected register 9.3% CAGR through 2027 owing to the cost effectiveness and noticeable outcomes of non-invasive aesthetic treatments. As per the data by International Society of Aesthetic Plastic Surgery, the number of non-surgical treatments carried out in Germany increased by 194% between 2016-2019.
 

Based on gender, Europe aesthetic medicine market is segmented into male (18 years & below, 19-34 years, 35-50 years, 51-64 years, and 65 years & above), and female (18 years & below, 19-34 years, 35-50 years, 51-64 years, and 65 years & above). Herein, the male segment generated revenues worth USD 650 million in 2020, on account of rising awareness about cosmetic procedures amongst men, and surge in spending power.
 

The end use spectrum of the marketplace comprises of hospitals, ambulatory surgical centers, beauty centers and medicinal spas dermatology clinics, and home settings. As per the report, ambulatory surgical centers segment is likely to expand modestly over 2021-2027, attributable to rapid increase in the number of minimally invasive cosmetic procedures, along with thriving medical tourism across the region, and cost-effectiveness of these centers as compared to hospital settings.
 

Major players operating in Europe aesthetic medicine market are Zimmer MedizinSysteme GmbH, BioScience GmbH, Johnson & Johnson, Cutera, Inc., PhotoMedex, Inc., Bausch Health Companies, Inc., Syneron Medical Ltd., Merz Pharma GmbH & Co. KGaA, Lumenis Ltd.,  Galderma S.A., Cynosure LLC, Alma Lasers Ltd., and AbbVie, Inc.